Sign in
Enrolling by invitationNo phase

Low-histamine diet for children and teens with long-lasting hives

Tests a low-histamine, pseudoallergen-free diet in young people with chronic spontaneous urticaria.

Key facts

Who runs it
Istanbul University
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Pseudoallergen-Free and Low-Histamine Diet in Adolescents With Chronic Spontaneous Urticaria
Status
Enrolling by invitation
People taking part
120 people, planned
Started
24 Nov 2025
Expected to end
Jan 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Intervention Name: Low-histamine and pseudoallergen-free diet
  • General healthy eating advice
Record updated
8 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children and teenagers with chronic spontaneous urticaria (long-lasting hives with no known cause) who have active symptoms. It tests a diet low in histamine and pseudoallergens (certain food additives and natural substances).

Age
1 Year to 18 Years
Sex
All
Disease stage
Chronic spontaneous urticaria lasting at least 6 weeks, with active hives at enrolment.
Earlier treatment
No oral corticosteroids in the previous 4 weeks. No current or recent biological treatment for chronic urticaria.

Main reasons for not taking part

  • Hives caused only by a physical trigger, or by another identified trigger
  • Food allergy that needs a specific elimination diet
  • Active infection or parasite disease
  • Coeliac disease, inflammatory bowel disease or known systemic mast cell disease
  • Pregnancy or breastfeeding in teenagers who have started having periods

The registry criteria, word for word

Show all 3 criteriaShow less

Who cannot take part

  • Pure chronic inducible urticaria Urticaria secondary to an identified trigger IgE-mediated food allergy requiring a specific elimination diet Active infection or parasitic disease Oral corticosteroid use within the previous 4 weeks Current or recent biological treatment for chronic urticaria Coeliac disease Inflammatory bowel disease Known systemic mast cell disease Severe chronic systemic disease affecting diet, growth, or follow-up Significant malnutrition or a medical condition requiring a special diet Pregnancy or lactation in postmenarchal adolescents Inability or unwillingness of the child or family to adhere to the assigned dietary recommendation Incomplete follow-up data

Other criteria

  • IInclusion Criteria:
  • Children aged 1 to 18 years Diagnosis of chronic spontaneous urticaria Disease duration of at least 6 weeks Presence of active urticaria symptoms at enrollment Ability of the child and/or parent/caregiver to complete symptom and diet follow-up forms Ability and willingness of the family to follow the assigned dietary recommendation Written informed consent from parent or legal guardian Assent from the child when applicable

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 1 and 18 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to learn whether a histamine- and pseudoallergen-restricted diet can help reduce symptoms in people with chronic urticaria. It will also learn whether this diet changes the need for urticaria medication.

Read full original descriptionShow less

The main questions it aims to answer are:

Does the diet lower urticaria activity, including hives and itching?

Does the diet improve disease control and quality of life?

Does the diet change the need for urticaria medication?

Which clinical or laboratory factors may affect response to the diet?

There is no comparison group. Researchers will compare participants' symptoms before and after the diet.

Participants will:

Follow a structured histamine- and pseudoallergen-restricted diet

Continue their usual urticaria treatment as recommended by their doctor

Record or report their urticaria symptoms during follow-up

Visit the clinic for assessment of symptoms, disease control, quality of life, medication use, and laboratory findings.

The 2 groups in the trial

  • Low-histamine and pseudoallergen-free diet groupTreatment being tested

    Children with chronic spontaneous urticaria assigned to this arm will receive a structured low-histamine and pseudoallergen-free diet in addition to standard guideline-based clinical care.

    Treatment: Intervention Name: Low-histamine and pseudoallergen-free diet

  • General dietary advice control groupExisting treatment, for comparison

    Children with chronic spontaneous urticaria assigned to this arm will receive standard guideline-based clinical care with general age-appropriate healthy eating advice, without specific restriction of histamine-rich or pseudoallergen-containing foods during the primary comparison period.

    Treatment: General healthy eating advice

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Clinical Response to a Histamine- and Pseudoallergen-Restricted Diet in Patients With Chronic Urticaria
Plain-language title
Low-histamine diet for children and teens with long-lasting hivesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT07632040, who can take part
Record updated
8 June 2026